CR
Crane Company
CR's fundamentals are mixed: revenue grew 22%, but earnings per share fell 6.6%. At 36x earnings, it's trading above its usual 31x. Analysts expect strong earnings growth.
CR Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Healthy | |
| Healthy | |
| Healthy |
CR's revenue, profitability, cash flow and balance sheet are all currently healthy.
CR PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 27x | $209 | — |
| Cheap | 29x | $167 | -20% |
| Fair | 31x | $180 | -14% |
| Expensive | 34x | $198 | -5.7% |
| Current | 36x | $209 | — |
Historical ranges are pointers, not guarantees.
CR's PE is in its expensive range at 36x. If earnings grow as analysts expect, today's price would be 27x next year's earnings, in its cheap range.
CR Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Improving | |
| Limited | |
| High |
Analysts expect earnings and revenue growth for CR, with profitability improving.
CR Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $7.81 | +34% |
| Q3 2026 | $5.83 | -6.6% |
| Q2 2026 | $5.73 | -4.7% |
| Q1 2026 | $5.57 | -3.5% |
| Q4 2025 | $6.26 | +24% |
| Q3 2025 | $6.24 | +18% |
| Q2 2025 | $6.01 | +22% |
| Q1 2025 | $5.77 | +29% |
| Q4 2024 | $5.06 | +14% |
CR's earnings per share have fallen from their peak: $5.83 over the past year, against $9.53 in mid-2022.
CR Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $754.6M | +28% |
| Q2 2026 | $724.7M | +26% |
| Q1 2026 | $696.4M | +25% |
| Q4 2025 | $581M | +6.8% |
| Q3 2025 | $589.2M | -1.3% |
| Q2 2025 | $577.2M | -0.7% |
| Q1 2025 | $557.6M | -1.4% |
| Q4 2024 | $544.1M | +2.1% |
CR's revenue is recovering but still below its 2021 peak: $755M last quarter, up 28% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 19% | -1.5 points |
| Q2 2026 | 20% | +2.1 points |
| Q1 2026 | 14% | -3.8 points |
| Q4 2025 | 18% | +1.7 points |
| Q3 2025 | 20% | +2.5 points |
| Q2 2025 | 18% | +1.2 points |
| Q1 2025 | 18% | +2.3 points |
| Q4 2024 | 16% | +3.3 points |
CR's operating margin was 19% last quarter, down 1.5 points from the same quarter a year ago.
CR Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $116.3M | -0.4% |
| Q2 2026 | $107.7M | +21% |
| Q1 2026 | -$40.2M | +$20.2M |
| Q4 2025 | $196M | +7.2% |
| Q3 2025 | $116.8M | +61% |
| Q2 2025 | $88.9M | +63% |
| Q1 2025 | -$60.4M | +$28.6M |
| Q4 2024 | $182.9M | +25% |
CR generated $380M in free cash flow over the past year, up 16% from the year before.
CR Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +100K shares |
| 1 year | +0.3% | +200K shares |
| 3 years | +2.3% | +1.3M shares |
| 5 years | -1.2% | -700K shares |
| Available history | -1.2% | -700K shares |
CR has 59M diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q4 2023 | — |
| Q3 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | $27.9M |
| Q1 2022 | $175.8M |
| Q4 2021 | $96.3M |
| Q3 2021 | — |
CR Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.1x | Healthy |
| Q2 2026 | 1.4x | Healthy |
| Q1 2026 | 1.7x | Healthy |
| Q4 2025 | 1.4x | Healthy |
| Q3 2025 | -0.9x | Net Cash |
| Q2 2025 | -0.6x | Net Cash |
| Q1 2025 | -0.4x | Net Cash |
| Q4 2024 | -0.1x | Net Cash |
CR's net debt is about 1.1 years of its operating earnings (EBITDA), after holding more cash than debt a year ago.
CR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.1 | Neutral |
| Stochastic | 47.0 | Neutral |
CR's weekly RSI is 54 (neutral) and its Stochastic is 47 (neutral).
CR PE vs Industrials Sector
| Metric | CR | Sector median | Relative |
|---|---|---|---|
| PE | 36x | 24x | 50% above |
| PE % | 91 | 59 | 32 pts above |
CR is trading at 36x earnings, a 50% premium to the Industrials sector's median of 24x.
CR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $202.1 | 3.6% above |
| 20 week MA | $208.4 | 0.5% above |
| 50 week MA | $197.0 | 6.3% above |
| 100 week MA | $184.9 | 13% above |
CR is in an uptrend: it's above all four of its weekly moving averages, and 13% above its 100-week average.
CR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2023 | $105.7 | $118.1 | +12% |
| 2024 | $118.1 | $153.9 | +30% |
| 2025 | $153.9 | $187.8 | +22% |
| 2026 YTD | $187.8 | $209.5 | +12% |
CR has finished every year since 2023 higher, and it's up 12% so far in 2026.